Eun-Sang Lee

Title: Innovations of Eun-Sang Lee in Biosensor Technology

Introduction

Eun-Sang Lee is a notable inventor based in Anyang-si, South Korea, recognized for his contributions to biosensor technology. With a total of 3 patents, his work focuses on enhancing the sensitivity and efficiency of biosensors, particularly in glucose analysis.

Latest Patents

One of Eun-Sang Lee's latest patents is a reagent composition for a biosensor that significantly improves analysis linearity for analytes such as glucose. This invention utilizes a combination of oxidoreductase, a metal-containing complex, and Naphthol Green B to achieve high sensitivity. The innovative aspect of this biosensor is its ability to minimize the blood volume required for glucose measurement, allowing for the detection of small concentrations of analytes. The reagent composition includes at least two types of electron transfer mediators, including Naphthol Green B, along with an enzyme, which enhances the overall performance of the biosensor.

Career Highlights

Eun-Sang Lee has worked with prominent companies in the technology sector, including Infopia Co., Ltd. and LG Electronics Inc. His experience in these organizations has contributed to his expertise in developing advanced biosensor technologies.

Collaborations

Eun-Sang Lee has collaborated with several professionals in his field, including coworkers Sung-Il Jeon and Sung-Kwon Jung. These collaborations have likely played a significant role in the development of his innovative biosensor solutions.

Conclusion

Eun-Sang Lee's work in biosensor technology exemplifies the impact of innovation in healthcare. His patents reflect a commitment to improving diagnostic methods, particularly in glucose monitoring, which can lead to better health outcomes for individuals.